We are an academic spin-off from Cologne developing proprietary liquid biopsy technology with razor-sharp sensitivity for detecting minimal residual disease. Our team combines deep scientific expertise with commercial ambition to bring breakthrough diagnostic solutions to cancer patients worldwide. We serve both clinical customers and the pharmaceutical industry with diagnostic testing and research services.
Join us in our mission to transform cancer care through innovative liquid biopsy solutions!
Our mission is to improve the lives of people with cancer by developing and providing tools to understand an individual cancer and how it responds to treatment accurately and timely. To do so we use Liquid Biopsies. We identify individual genetic signatures of a cancer in a blood sample of a patient and track these signatures over time.